当前位置:首页 - 行情中心 - 立方制药(003020) - 财务分析 - 现金流量表

立方制药

(003020)

  

流通市值:25.77亿  总市值:34.89亿
流通股本:1.69亿   总股本:2.28亿

现金流量表

报告期2026-09-302026-06-302026-03-312025-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金1,183,963,370.15833,710,494.11416,176,012.551,646,994,726.18
  收到的税费返还461,118.27456,393.56,837.0318,636,426.92
  收到其他与经营活动有关的现金26,530,722.3914,385,338.7518,062,88371,794,398.39
  经营活动现金流入小计1,210,955,210.81848,552,226.36434,245,732.581,737,425,551.49
  购买商品、接受劳务支付的现金286,668,064.61205,005,613.43131,639,558.11499,001,575.37
  支付给职工以及为职工支付的现金162,266,321.49116,235,082.9562,463,470.64208,698,025.06
  支付的各项税费127,103,685.2583,402,595.9943,796,070.44187,201,861.82
  支付其他与经营活动有关的现金428,474,814.09281,437,277.38132,675,797.66629,638,871.54
  经营活动现金流出小计1,004,512,885.44686,080,569.75370,574,896.851,524,540,333.79
  经营活动产生的现金流量净额206,442,325.37162,471,656.6163,670,835.73212,885,217.7
二、投资活动产生的现金流量:
  收回投资收到的现金987,990,000474,990,000160,000,000938,789,470.8
  取得投资收益收到的现金8,588,029.619,688,405.86627,858.4724,522,190.12
  处置固定资产、无形资产和其他长期资产收回的现金净额414,335.12330,237.951,779.758,004,480.76
  收到的其他与投资活动有关的现金3,157,621.69---
  投资活动现金流入小计1,000,149,986.42485,008,643.81160,629,638.22971,316,141.68
  购建固定资产、无形资产和其他长期资产支付的现金77,681,934.0962,752,865.4730,129,805.62118,456,422.41
  投资支付的现金1,164,990,000739,990,000330,000,000911,860,000
  支付其他与投资活动有关的现金6,975,703.97---
  投资活动现金流出小计1,249,647,638.06802,742,865.47360,129,805.621,030,316,422.41
  投资活动产生的现金流量净额-249,497,651.64-317,734,221.66-199,500,167.4-59,000,280.73
三、筹资活动产生的现金流量:
  吸收投资收到的现金---25,300
  取得借款收到的现金69,181,591.4330,000,00010,000,000-
  收到其他与筹资活动有关的现金501,75577,855-1,140,521.75
  筹资活动现金流入小计69,683,346.4330,077,85510,000,0001,165,821.75
  偿还债务支付的现金1,600,0001,550,000--
  分配股利、利润或偿付利息支付的现金58,553,765.1657,928,817.94406,471.11166,163,772.32
  支付其他与筹资活动有关的现金23,660,472.3712,253,072.042,516,170.4514,628,271.86
  筹资活动现金流出小计83,814,237.5371,731,889.982,922,641.56180,792,044.18
  筹资活动产生的现金流量净额-14,130,891.1-41,654,034.987,077,358.44-179,626,222.43
四、汇率变动对现金及现金等价物的影响-119,568.97-99,521.94-79,524.7-59,152.46
五、现金及现金等价物净增加额-57,305,786.34-197,016,121.97-128,831,497.93-25,800,437.92
  加:期初现金及现金等价物余额413,893,621.67413,893,621.67413,893,621.67439,694,059.59
  期末现金及现金等价物余额356,587,835.33216,877,499.7285,062,123.74413,893,621.67
补充资料:
  净利润-85,085,713.78-163,551,446.54
  资产减值准备-4,177,665.87-11,469,964.79
  固定资产和投资性房地产折旧-39,983,010.64-74,837,921.3
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-39,983,010.64-74,837,921.3
  无形资产摊销-4,855,791.19-9,790,058.12
  长期待摊费用摊销-1,036,579.82-2,773,038.38
  处置固定资产、无形资产和其他长期资产的损失--49,792.43-1,677.88
  固定资产报废损失-6,641.53-652,887.92
  公允价值变动损失--313,697.46--149,013.75
  财务费用-1,083,461.87-2,398,963.88
  投资损失--3,040,602.85--27,718,188.08
  递延所得税--2,251,370.45--2,872,314.75
  其中:递延所得税资产减少--1,511,555.62--1,301,300.35
    递延所得税负债增加--739,814.83--1,571,014.4
  存货的减少--47,090,245.89-5,348,254.16
  经营性应收项目的减少-67,808,841.65--26,739,536.81
  经营性应付项目的增加-6,560,056.35--6,610,805.57
  其他-2,120,154.13-298,212.33
  融资租入固定资产---1,625,611.21
  现金的期末余额-216,877,499.7-413,893,621.67
  减:现金的期初余额-413,893,621.67-439,694,059.59
  现金及现金等价物的净增加额--197,016,121.97--25,800,437.92
公告日期2026-10-302026-08-292026-04-282026-04-28
审计意见(境内)标准无保留意见
TOP↑